drugset / Trial / NCT01289574

Topical ASC-J9 Cream for Acne

NCT01289574 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and efficacy of topical 0.1% and 0.025% ASC-J9 creams applied twice daily for facial acne compared to vehicle control.

Timeline

Start
2011-02
Primary completion
2012-07
Completion
2012-08

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Vehicle Control Cream vs 0.025% ASC-J9 Cream vs 0.1% ASC-J9 Cream; p = 0.1919; Cochran-Mantel-Haenszel NCT01289574 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject DIMETHYLCURCUMIN Small molecule 0.025 % Topical
Subject DIMETHYLCURCUMIN Small molecule 0.1 % Topical

Indications